HIV Drugs and Alzheimer's; Duchenne Drug Shows Benefit; PFAS and Cognitive Changes

(MedPage Today) — Nucleoside reverse transcriptase inhibitors — antiretroviral drugs approved to treat HIV and hepatitis B — were associated with a lower incidence of Alzheimer’s disease in two large insurance databases. (Alzheimer’s &amp…

Source link : https://www.medpagetoday.com/neurology/generalneurology/115568

Author :

Publish date : 2025-05-13 18:41:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

HIV Drugs and Alzheimer’s; Duchenne Drug Shows Benefit; PFAS and Cognitive Changes

Low LDL and Bleeding Risk; Improved HoFH Life Expectancy; ANGPTL4 mAb Progress

Doctors, Other Healthcare Workers Strike in Washington State

Related Posts

‘5 Years, 10 Years at Most, I’m Going to Retire’: What We Heard This Week

Once-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 Diabetes

Combo Semaglutide-Amylin Analogue Boosts Weight Loss Regardless of Diabetes

Can Behavioral Support Enhance CGM Use in T1D?

Fewer ECG Abnormalities in Early T2D With Combo Therapy

No budget for assisted dying service, health secretary says

‘5 Years, 10 Years at Most, I’m Going to Retire’: What We Heard This Week

Once-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 Diabetes

Combo Semaglutide-Amylin Analogue Boosts Weight Loss Regardless of Diabetes

Can Behavioral Support Enhance CGM Use in T1D?

Fewer ECG Abnormalities in Early T2D With Combo Therapy

No budget for assisted dying service, health secretary says

I Want You, Doctor, to Run for Office

NFL Widows Say a New Study on CTE in Players Minimizes Their Pain

Categories

Archives